USPH US Physical Therapy Inc

Declares Quarterly Dividend

U.S. Physical Therapy, Inc. ("USPH" or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics, today reported results for the first quarter ended March 31, 2018.

For the quarter ended March 31, 2018, USPH’s Operating Results increased 10.6% to $7.1 million, or $.56 per diluted share, as compared to $6.4 million, or $.51 per diluted share, in the first quarter of 2017. Operating Results, a non-generally accepted accounting principles (“non-GAAP”) measure, for the 2018 first quarter equals net income attributable to USPH shareholders. For the 2017 first quarter, Operating Results, is defined as net income attributable to common shareholders prior to interest expense – mandatorily redeemable non-controlling interests – change in redemption value, net of tax.

For the quarter ended March 31, 2018, USPH’s net income attributable to its shareholders, in accordance with generally accepted accounting principles (“GAAP”), was $7.1 million as compared to $4.8 million for the first quarter of 2017. Earnings per diluted share of $0.27 in the first quarter of 2018 compares to $0.38 per diluted share for the 2017 first quarter. For 2018, in accordance with current accounting guidance, the revaluation of redeemable non-controlling interest, net of tax, which is charged directly to retained earnings, is included in the earnings per basic and diluted share calculation. See the schedule on page 11 for a computation of diluted earnings per share and a reconciliation of net income attributable to USPH shareholders to Operating Results.

First Quarter 2018 Compared to First Quarter 2017

• Net revenues increased $10.8 million or 11.0% from $97.6 million in the 2017 first quarter to $108.3 million in the 2018 first quarter, primarily due to a 7.4% increase in net patient revenues from the physical therapy operations, an increase of 20.4% in revenue from management contracts and an increase in the revenue from the industrial injury prevention business due to a full quarter of operations versus one month in the 2017 period. The industrial injury prevention business was acquired in March 2017.
• Net patient revenues from physical therapy operations increased approximately $6.9 million, or 7.4%, to $100.6 million in the 2018 first quarter from $93.7 million in the 2017 first quarter due to an increase in total patient visits of 7.2% from 892,000 to 956,000 and an increase in the average net patient revenue per visit to $105.15 from $105.04. Of the $6.9 million increase, $5.9 million related to clinics opened or acquired after March 31, 2017 (“New Clinics”) and an increase of $1.0 million in net patient revenues related to clinics opened or acquired prior to April 1, 2017 (“Mature Clinics”).
• Revenue from management contracts was $2.2 million in the 2018 first quarter as compared to $1.9 million for the 2017 first quarter. The revenue from the industrial injury prevention business was $4.9 million for the 2018 first quarter compared to $1.5 million in the 2017 first quarter. Other revenue was $0.7 million in the 2018 first quarter and $0.5 million in the 2017 period.
• Total operating costs were $85.1 million, or 78.6% of net revenues, in the 2018 first quarter as compared to $76.8 million, or 78.7% of net revenues, in the 2017 first quarter. The $8.3 million increase was attributable to $5.5 million in operating costs related to New Clinics, an increase of $2.8 million related to the industrial injury prevention business due to a full quarter of operations and an increase of $0.3 million related to management contracts while costs of Mature Clinics were reduced by $0.3 million. Total salaries and related costs, including those from New Clinics, were 57.5% of net revenue in the recent quarter versus 57.2% for the 2017 first quarter. Rent, supplies, contract labor and other costs as a percentage of net revenue were 20.1% for the recent quarter versus 20.6% for the 2017 first quarter. The provision for doubtful accounts as a percentage of net revenue was 1.0% for the 2018 first quarter as compared to 0.9% in the 2017 first quarter.
• The gross profit for the 2018 first quarter grew by $2.5 million, or 11.9%, to $23.2 million, as compared to $20.7 million in the first quarter of 2017. The gross profit percentage was 21.4% of net revenue in the recent period as compared to 21.3% for the 2017 first quarter. The gross profit percentage for the Company’s physical therapy clinics was 21.9% in the recent quarter as compared to 21.5% in the 2017 first quarter. The gross profit percentage on management contracts was 13.8% in the 2018 first quarter as compared to 14.8% in the 2017 first quarter. The gross profit percentage for the industrial injury prevention business was 15.8% for the recent quarter as compared to 14.3% for the one month of operation in the 2017 period.
• Corporate office costs were $10.2 million in the 2018 first quarter compared to $8.5 million in the 2017 first quarter. Corporate office costs were 9.4% of net revenues for the 2018 first quarter compared to 8.8% for the 2017 first quarter.
• Operating income for the recent quarter increased 7.0% to $13.1 million as compared to $12.2 million in the 2017 first quarter.

• The Company no longer has mandatorily redeemable non-controlling interest. See discussion following – Redeemable Non-Controlling Interests.

• Interest expense – debt and other was $0.6 million in the 2018 first quarter and $0.4 million in the 2017 first quarter.
• The provision for income tax for the 2018 first quarter was $2.5 million and for the 2017 first quarter was $1.8 million both of which are inclusive of the reduction of $0.3 million and $0.8 million, respectively, for the excess tax benefit, which is a component of the provision for income taxes, related to equity compensation. The provision for income tax as a percentage of income before taxes less net income attributable to non-controlling interest was 25.8% and 27.3%, respectively, for the 2018 and 2017 first quarters.
• Net income attributable to non-controlling interests (permanent equity) was $1.2 million in the 2018 first quarter as compared to $1.2 million in the 2017 first quarter. Net income attributable to redeemable non-controlling interests (temporary equity) was $1.7 million in the 2018 first quarter.

• Same store revenues for de novo and acquired clinics open for one year or more increased 1.9%. Visits increased 1.4% for de novo and acquired clinics open for one year or more and the same store net rate increased by approximately 0.5%.

Other Financial Measures

For the first quarter of 2018 the Company's Adjusted EBITDA increased by 4.8% to $14.0 million from $13.3 million in the comparable 2017 quarter. See definition and explanation of Adjusted EBITDA in the schedule on pages 10 and 11.

Management’s Comments

Chris Reading, Chief Executive Officer, said, “We built a good, sturdy foundation this first quarter to start off the year on solid footing. Our core physical therapy business as well as our industrial injury prevention initiatives are growing and realizing margin expansion despite the extreme weather experienced in the first part of the year. Our leadership and operations team additions are working well and their impact should increase as the year progresses. Finally, we are excited about our newest acquisition within our industrial injury prevention business and the opportunities we are seeing to continue to grow and scale that part of our service offering.”

Larry McAfee, Chief Financial Officer, noted, “The Company’s net cash flow from operations in the first quarter of 2018 was strong as evidenced by the $12.7 million or 21% reduction in debt as compared to year-end 2017.”

Redeemable Non-Controlling Interests

Effective December 31, 2017, the Company entered into amendments to its acquired limited partnership agreements replacing the mandatory redemption feature. No monetary consideration was paid to the partners to amend the agreements. The amended Partnership Agreements provide that, upon certain events, the Company has a call right (the “Call Right”) and the selling entity has a put right (the “Put Right”) for the purchase and sale of the limited partnership interest held by the partner. Once the terms are triggered, the Put Right and the Call Right do not expire, even upon an individual partner’s death, and contain no mandatory redemption feature. The purchase price of the partner’s limited partnership interest upon the exercise of either the Put Right or the Call Right is calculated per the original terms of the respective agreements. The Company accounted for the amendment of its Partnership Agreements as an extinguishment of the outstanding Seller Entity Interests classified as liabilities through the issuance of new Seller Entity Interests classified in temporary equity. Pursuant to ASC 470-50-40-2, the Company removed the outstanding liability-classified Seller Entity Interests at their carrying amounts and recognized the new temporary-equity-classified Seller Entity Interests at their fair value. In summary, the redemption values of the mandatorily redeemable non-controlling interest (previously classified as liabilities) were reclassified as redeemable non-controlling interest (temporary equity) on the December 31, 2017 consolidated balance sheet. For 2018, in accordance with current accounting guidance, the revaluation of redeemable non-controlling interest, net of tax, will be charged directly to retained earnings and will be included in the earnings per basic and diluted share calculation.

U.S. Physical Therapy Declares Quarterly Dividend

The second quarterly dividend for 2018 of $0.23 per share will be paid on June 8, 2018 to shareholders of record as of May 11, 2018. U.S. Physical Therapy began paying quarterly dividends in 2011 and has increased the dividend amount every year since.

First Quarter 2018 Conference Call

U.S. Physical Therapy's Management will host a conference call at 10:30 a.m. Eastern Time, 9:30 a.m. Central Time, on May 3, 2018 to discuss the Company's Quarter Ended March 31, 2018 results. Interested parties may participate in the call by dialing 1-888-335-5539 or 973-582-2857 and entering reservation number 4398474 approximately 10 minutes before the call is scheduled to begin. To listen to the live call via web-cast, go to the Company's website at www.usph.com at least 15 minutes early to register, download and install any necessary audio software. The conference call will be archived and can be accessed until August 3, 2018.

Forward-Looking Statements

This press release contains statements that are considered to be forward-looking within the meaning under Section 21E of the Securities Exchange Act of 1934, as amended. These statements contain forward-looking information relating to the financial condition, results of operations, plans, objectives, future performance and business of our Company. These statements (often using words such as “believes”, “expects”, “intends”, “plans”, “appear”, “should” and similar words) involve risks and uncertainties that could cause actual results to differ materially from those we expect. Included among such statements may be those relating to new clinics, availability of personnel and the reimbursement environment. The forward-looking statements are based on our current views and assumptions and actual results could differ materially from those anticipated in such forward-looking statements as a result of certain risks, uncertainties, and factors, which include, but are not limited to:

• changes as the result of government enacted national healthcare reform;
• changes in Medicare rules and guidelines and reimbursement or failure of our clinics to maintain their Medicare certification status;
• revenue we receive from Medicare and Medicaid being subject to potential retroactive reduction;
• business and regulatory conditions including federal and state regulations;
• governmental and other third party payor inspections, reviews, investigations and audits;
• compliance with federal and state laws and regulations relating to the privacy of individually identifiable patient information, and associated fines and penalties for failure to comply;
• changes in reimbursement rates or payment methods from third party payors including government agencies and deductibles and co-pays owed by patients;
• revenue and earnings expectations;
• cost, risks and uncertainties associated with the Company’s restatement of its prior financial statements due to the correction of its accounting methodology for redeemable non-controlling partnership interests, and including any pending and future claims or proceedings relating to such matters;
• legal actions, which could subject us to increased operating costs and uninsured liabilities;
• general economic conditions;
• availability and cost of qualified physical therapists;
• personnel productivity and retaining key personnel;
• competitive, economic or reimbursement conditions in our markets which may require us to reorganize or close certain clinics and thereby incur losses and/or closure costs including the possible write-down or write-off of goodwill and other intangible assets;
• acquisitions, purchase of non-controlling interests (minority interests) and the successful integration of the operations of the acquired businesses;
• maintaining our information technology systems with adequate safeguards to protect against cyber-attacks;
• maintaining adequate internal controls;
• maintaining necessary insurance coverage;
• availability, terms, and use of capital; and
• weather and other seasonal factors.

Many factors are beyond our control. Given these uncertainties, you should not place undue reliance on our forward-looking statements. Please see our periodic reports filed with the Securities and Exchange Commission for more information on these factors. Our forward-looking statements represent our estimates and assumptions only as of the date of this press release. Except as required by law, we are under no obligation to update any forward-looking statement, regardless of the reason the statement is no longer accurate.

About U.S. Physical Therapy, Inc.

Founded in 1990, U.S. Physical Therapy, Inc. operates 580 outpatient physical therapy clinics in 42 states. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. In addition to owning and operating clinics, the Company manages 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The Company also has an industrial injury prevention business which provides onsite services for clients’ employees including injury prevention, rehabilitation, ergonomic assessments and performance optimization.

More information about U.S. Physical Therapy, Inc. is available at www.usph.com. The information included on that website is not incorporated into this press release.

   

U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF NET INCOME

(IN THOUSANDS, EXCEPT PER SHARE DATA)

(unaudited)

  Three Months Ended March 31, 2018     March 31, 2017   Net patient revenues $ 100,552 $ 93,654 Other revenues   7,790   3,911 Net revenues 108,342 97,565 Operating costs: Salaries and related costs 62,279 55,827 Rent, supplies, contract labor and other 21,776 20,087 Provision for doubtful accounts 1,061 898 Closure costs   12   6 Total operating costs   85,128   76,818   Gross profit 23,214 20,747   Corporate office costs   10,163   8,547 Operating income 13,051 12,200   Interest and other income, net 32 24 Interest expense: Mandatorily redeemable non-controlling interests - change in redemption value - (2,669 ) Mandatorily redeemable non-controlling interests - earnings allocable - (1,294 ) Debt and other   (553 )   (415 ) Total interest expense (553 ) (4,378 )   Income before taxes 12,530 7,846   Provision for income taxes   2,476   1,812   Net income 10,054 6,034   Less: net income attributable to non-controlling interests   (2,937 )   (1,218 )   Net income attributable to USPH shareholders $ 7,117 $ 4,816   Basic and diluted earnings per share attributable to USPH shareholders $ 0.27 $ 0.38   Shares used in computation - basic and diluted   12,616   12,528   Dividends declared per common share $ 0.23 $ 0.20          

U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES

 

CONSOLIDATED BALANCE SHEETS

(IN THOUSANDS, EXCEPT SHARE DATA)

  March 31, 2018 December 31, 2017 ASSETS (unaudited) Current assets: Cash and cash equivalents $ 19,813 $ 21,933 Patient accounts receivable, less allowance for doubtful accounts of $2,517 and $2,273, respectively 46,228 44,707 Accounts receivable - other 6,504 5,655 Other current assets   3,050   4,786 Total current assets 75,595 77,081 Fixed assets: Furniture and equipment 51,569 51,100 Leasehold improvements   29,981   29,760 Fixed assets, gross 81,550 80,860 Less accumulated depreciation and amortization   61,742   60,475 Fixed assets, net 19,808 20,385 Goodwill 273,770 271,338 Other identifiable intangible assets, net 47,092 48,954 Other assets   1,357   1,224 Total assets $ 417,622 $ 418,982   LIABILITIES, REDEEMABLE NON-CONTROLLING INTERESTS, USPH SHAREHOLDERS' EQUITY AND NON-CONTROLLING INTERESTS Current liabilities: Accounts payable - trade $ 1,722 $ 2,165 Accrued expenses 38,342 33,342 Current portion of notes payable   5,317   4,044 Total current liabilities 45,381 39,551 Notes payable, net of current portion 782 2,728 Revolving line of credit 42,000 54,000 Mandatorily redeemable non-controlling interests - 327 Deferred taxes 10,151 10,875 Deferred rent 2,005 2,116 Other long-term liabilities   733   743 Total liabilities 101,052 110,340   Redeemable non-controlling interests 108,085 102,572   Commitments and contingencies   U.S. Physical Therapy, Inc. ("USPH") shareholders' equity: Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding - - Common stock, $.01 par value, 20,000,000 shares authorized, 14,884,676 and 14,809,299 shares issued, respectively 149 148 Additional paid-in capital 75,543 73,940 Retained earnings 162,907 162,406 Treasury stock at cost, 2,214,737 shares   (31,628 )   (31,628 ) Total USPH shareholders' equity 206,971 204,866 Non-controlling interests   1,514   1,204 Total USPH shareholders' equity and non-controlling interests   208,485   206,070 Total liabilities, redeemable non-controlling interests, USPH shareholders' equity and non-controlling interests $ 417,622 $ 418,982  

U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(IN THOUSANDS, EXCEPT PER SHARE DATA)

(unaudited)

    Three Months Ended March 31, 2018     March 31, 2017 OPERATING ACTIVITIES Net income including non-controlling interests $ 10,054 $ 6,034 Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities: Depreciation and amortization 2,468 2,356 Provision for doubtful accounts 1,061 898 Equity-based awards compensation expense 1,381 1,280 Loss on sale of fixed assets 54 33 Deferred income taxes (1,162 ) (250 ) Changes in operating assets and liabilities: Increase in patient accounts receivable (2,782 ) (1,542 ) Increase in accounts receivable - other (849 ) (3,697 ) (Increase) decrease in other assets (1,238 ) 757 Increase in accounts payable and accrued expenses 7,389 5,315 Increase in mandatorily redeemable non-controlling interests - 2,911 (Decrease) increase in other liabilities   (845 )   76 Net cash provided by operating activities 15,531 14,171   INVESTING ACTIVITIES Purchase of fixed assets (1,404 ) (1,587 ) Purchase of businesses, net of cash acquired (761 ) (15,670 ) Purchase of non-controlling interest (246 ) - Proceeds on sale of fixed assets   -   62 Net cash used in investing activities (2,411 ) (17,195 )   FINANCING ACTIVITIES Distributions to non-controlling interests, permanent and temporary equity (2,208 ) (937 ) Proceeds from revolving line of credit 19,000 32,000 Payments on revolving line of credit (31,000 ) (20,000 ) Payments to settle mandatorily redeemable non-controlling interests (265 ) (2,230 ) Principal payments on notes payable (823 ) (702 ) Other   56   - Net (cash used in) provided by financing activities (15,240 ) 8,131   Net increase in cash and cash equivalents (2,120 ) 5,107 Cash and cash equivalents - beginning of period   21,933   20,047 Cash and cash equivalents - end of period $ 19,813 $ 25,154   SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION Cash paid during the period for: Income taxes $ 2,941 $ 86 Interest $ 526 $ 599 Non-cash investing and financing transactions during the period: Purchase of business - seller financing portion $ 150 $ 900  

U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES

 

OPERATING RESULTS AND ADJUSTED EBITDA

(IN THOUSANDS, EXCEPT PER SHARE DATA)

(unaudited)

The following tables provide a detail of the diluted earnings per share computation and reconcile net income attributable to USPH shareholders calculated in accordance with GAAP to Operating Results and Adjusted EBITDA. Management believes providing Operating Results and Adjusted EBITDA to investors is useful information for comparing the Company's period-to-period results.

For 2018, Operating Results equal net income attributable to USPH shareholders and, in accordance with current accounting guidance, the revaluation of redeemable non-controlling interest, net of tax, charged directly to retained earnings is included in the earnings per diluted share calculation. For the 2017 first quarter, Operating Results, a non-generally accepted accounting principles (“non-GAAP”) measure, is defined as net income attributable to common shareholders prior to interest expense – mandatorily redeemable non-controlling interests – change in redemption value, net of tax. Operating Results for the two periods are comparable, however, the calculations differ. Management uses Operating Results, which eliminates this current non-cash item that can be subject to volatility and unusual costs, as one of the principal measures to evaluate and monitor financial performance period over period. Management believes that Operating Results is useful information for investors to use in comparing the Company's period-to-period results as well as for comparing with other similar businesses since most do not have mandatorily redeemable instruments and therefore have different liability and equity structures.

Adjusted EBITDA is defined as earnings before interest income, interest expense – mandatorily redeemable non-controlling interests – change in redemption value, interest expense – debt and other, taxes, depreciation, amortization and equity-based awards compensation expense. Management believes reporting Adjusted EBITDA is useful information for investors in comparing the Company’s period-to-period results as well as comparing with similar businesses which report adjusted EBITDA as defined by their company.

Operating Results and Adjusted EBITDA are not measures of financial performance under GAAP. Adjusted EBITDA and Adjusted Net Income should not be considered in isolation or as an alternative to, or substitute for, net income attributable to USPH shareholders presented in the consolidated financial statements.

    Three Months Ended March 31, 2018     2017 Computation of earnings per share - USPH shareholders   Net income attributable to USPH shareholders $ 7,117 $ 4,816 Charges to retained earnings: Revaluation of redeemable non-controlling interest $ (5,081 ) $ - Tax effect at statutory rate (federal and state) of 26.25%   1,334   - $ 3,370 $ 4,816   Basic and diluted per share $ 0.27 $ 0.38   Adjustments: Interest expense MRNCI * - change in redemption value - 2,669 Revaluation of redeemable non-controlling interest 5,081 - Tax effect at statutory rate (federal and state) of 26.25% and 39.25%, respectively   (1,334 )   (1,048 ) Operating results $ 7,117 $ 6,437   Basic and diluted operating results per share $ 0.56 $ 0.51   Shares used in computation - basic and diluted   12,616   12,528     Three Months Ended March 31, 2018 2017   Net income attributable to USPH shareholders $ 7,117 $ 4,816   Adjustments: Depreciation and amortization 2,468 2,356 Interest income (32 ) (24 ) Interest expense MRNCI * - change in redemption value - 2,669 Interest expense - debt and other 553 415 Provision for income taxes 2,476 1,812 Equity-based awards compensation expense   1,381   1,280   Adjusted EBITDA $ 13,963 $ 13,324  

* Mandatorily redeemable non-controlling interest

 

U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES

RECAP OF CLINIC COUNT

  Date Number of Clinics   March 31, 2017 558 June 30, 2017 566 September 30, 2017 569 December 31, 2017 578   March 31, 2018 580

View source version on businesswire.com: https://www.businesswire.com/news/home/20180503005186/en/

U.S. Physical Therapy, Inc.Larry McAfee, (713) 297-7000Chief Financial OfficerorChris Reading, (713) 297-7000Chief Executive OfficerorThree Part AdvisorsJoe Noyons, (817) 778-8424